Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Soliris – Treatment for PNH, aHUS, gMG, and NMOSD

Drug name (Brand / Generic)

Soliris / Eculizumab

Company / Licensee

Alexion Pharmaceuticals

Therapy Class

Complement inhibitor

Drug Indication

Paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome

Market Sector

Haematology

Development Status

Approved in US, EU and Asia for PNH, approved in US for aHUS
Expand
Close
Close
Close

Go Top